Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 26 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//DROSOPHILA | 115684 |
| 1154 | 2 | TGF BETA//SMAD//ENDOGLIN | 9841 |
| 12410 | 1 | ALK5 INHIBITOR//GALUNISERTIB//ALK5 | 938 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ALK5 INHIBITOR | authKW | 511047 | 2% | 89% | 17 |
| 2 | GALUNISERTIB | authKW | 279984 | 1% | 83% | 10 |
| 3 | ALK5 | authKW | 240152 | 2% | 31% | 23 |
| 4 | CELL BASED LUCIFERASE REPORTER ASSAY | authKW | 205789 | 1% | 88% | 7 |
| 5 | TGF BETA | authKW | 200198 | 20% | 3% | 189 |
| 6 | TGF BETA INHIBITION | authKW | 149661 | 1% | 64% | 7 |
| 7 | LY2157299 | authKW | 134394 | 0% | 100% | 4 |
| 8 | SD 208 | authKW | 100796 | 0% | 100% | 3 |
| 9 | T BETA RIII | authKW | 100796 | 0% | 100% | 3 |
| 10 | BETAGLYCAN | authKW | 90187 | 1% | 19% | 14 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 8439 | 49% | 0% | 462 |
| 2 | Cell Biology | 792 | 16% | 0% | 154 |
| 3 | Chemistry, Medicinal | 237 | 5% | 0% | 51 |
| 4 | Medicine, Research & Experimental | 232 | 7% | 0% | 66 |
| 5 | Biochemistry & Molecular Biology | 157 | 15% | 0% | 141 |
| 6 | Pharmacology & Pharmacy | 93 | 8% | 0% | 79 |
| 7 | Gastroenterology & Hepatology | 80 | 4% | 0% | 33 |
| 8 | Immunology | 58 | 6% | 0% | 53 |
| 9 | Pathology | 37 | 2% | 0% | 23 |
| 10 | Urology & Nephrology | 31 | 2% | 0% | 23 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ONCOL CELL SIGNALING | 89593 | 0% | 67% | 4 |
| 2 | CELL STRUCT MOL BIOL | 67197 | 0% | 100% | 2 |
| 3 | EARLY PHASE CLIN INVEST | 67197 | 0% | 100% | 2 |
| 4 | MED IMI | 67197 | 0% | 100% | 2 |
| 5 | RECEPTOR GROWTH TOR | 67197 | 0% | 100% | 2 |
| 6 | ONCOL EARLY CLIN INVEST | 44797 | 0% | 67% | 2 |
| 7 | LEAD OPTIMIZAT BIOL | 44793 | 0% | 33% | 4 |
| 8 | ACUPUNCTURE MOXIBUST TIANJIN | 33599 | 0% | 100% | 1 |
| 9 | AFFLLIATED TUMOR HOSP | 33599 | 0% | 100% | 1 |
| 10 | ANTIBODY TECHNOL IMMUNOL | 33599 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER RESEARCH | 2334 | 6% | 0% | 53 |
| 2 | CLINICAL CANCER RESEARCH | 1806 | 3% | 0% | 29 |
| 3 | BREAST CANCER RESEARCH | 1199 | 1% | 0% | 9 |
| 4 | CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 1155 | 1% | 0% | 7 |
| 5 | ONCOLOGY REPORTS | 1136 | 2% | 0% | 19 |
| 6 | TUMOR BIOLOGY | 935 | 1% | 0% | 14 |
| 7 | NEOPLASIA | 930 | 1% | 0% | 7 |
| 8 | JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA | 847 | 0% | 1% | 4 |
| 9 | CYTOKINE & GROWTH FACTOR REVIEWS | 632 | 0% | 0% | 4 |
| 10 | INTERNATIONAL JOURNAL OF CANCER | 623 | 2% | 0% | 20 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ALK5 INHIBITOR | 511047 | 2% | 89% | 17 | Search ALK5+INHIBITOR | Search ALK5+INHIBITOR |
| 2 | GALUNISERTIB | 279984 | 1% | 83% | 10 | Search GALUNISERTIB | Search GALUNISERTIB |
| 3 | ALK5 | 240152 | 2% | 31% | 23 | Search ALK5 | Search ALK5 |
| 4 | CELL BASED LUCIFERASE REPORTER ASSAY | 205789 | 1% | 88% | 7 | Search CELL+BASED+LUCIFERASE+REPORTER+ASSAY | Search CELL+BASED+LUCIFERASE+REPORTER+ASSAY |
| 5 | TGF BETA | 200198 | 20% | 3% | 189 | Search TGF+BETA | Search TGF+BETA |
| 6 | TGF BETA INHIBITION | 149661 | 1% | 64% | 7 | Search TGF+BETA+INHIBITION | Search TGF+BETA+INHIBITION |
| 7 | LY2157299 | 134394 | 0% | 100% | 4 | Search LY2157299 | Search LY2157299 |
| 8 | SD 208 | 100796 | 0% | 100% | 3 | Search SD+208 | Search SD+208 |
| 9 | T BETA RIII | 100796 | 0% | 100% | 3 | Search T+BETA+RIII | Search T+BETA+RIII |
| 10 | BETAGLYCAN | 90187 | 1% | 19% | 14 | Search BETAGLYCAN | Search BETAGLYCAN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |